Page 167 - 《南京医科大学学报》2026年第1期

第46卷第1期 张晓璐，李杉姗，徐 颖. LON蛋白酶1在疾病中的研究进展［J］.
2026年1月 南京医科大学学报（自然科学版），2026，46（1）：153-162 · 161 ·

［28］TANG P，ZENG Q，LI Y H，et al. The mitochondrial ticancer therapeutics［J］. Expert Opin Ther Targets，
LONP1 protease：molecular targets and role in pathophysi⁃ 2024，28（1⁃2）：9-15
ology［J］. Mol Biol Rep，2025，52（1）：401 ［42］GHOSH J C，SEO J H，AGARWAL E，et al. Akt phosphory⁃
［29］ZANINI G，SELLERI V，MALERBA M，et al. The role of lation of mitochondrial Lonp1 protease enables oxidative
Lonp1 on mitochondrial functions during cardiovascular metabolism and advanced tumor traits［J］. Oncogene，
and muscular diseases［J］. Antioxidants（Basel），2023，12 2019，38（43）：6926-6939
（3）：598 ［43］GIBELLINI L，LOSI L，DE BIASI S，et al. LonP1 differ⁃
［30］KIM Y，TRIOLO M，HOOD D A. Impact of aging and ently modulates mitochondrial function and bioenergetics
exercise on mitochondrial quality control in skeletal mus⁃ of primary versus metastatic colon cancer cells［J］. Front
cle［J］. Oxid Med Cell Longev，2017，2017：3165396 ⁃ Oncol，2018，8：254
3165396 ［44］LIU C，WANG H，LI H，et al. Inhibition of LONP1 sup⁃
［31］DELAVAL E，PERICHON M，FRIGUET B. Age⁃related presses pancreatic cancer progression via c⁃Jun N⁃Termi⁃
impairment of mitochondrial matrix aconitase and ATP ⁃ nal kinase pathway ⁃ meditated epithelial ⁃ mesenchymal
stimulated protease in rat liver and heart［J］. Eur J Bio⁃ transition［J］. Pancreas，2019，48（5）：629-635
chem，2004，271（22）：4559-4564 ［45］WANG X N，XU X，ZHAO Y，et al. Inhibition of Lonp1 in⁃
［32］ZHU W，TAN C，ZHANG J. Aging of alveolar type 2 cells duces mitochondrial remodeling and autophagy suppres⁃
induced by LONP1 deficiency exacerbates pulmonary fi⁃ sion in cervical cancer cells［J］. Acta Histochemical，
brosis［J］. Biomol Biomed，2024，24（5）：1258-1272 2023，125（1）：151986
［33］ZHANG C，SHEN S，XU L，et al. LONP1 alleviates ageing ［46］LUO B，WANG M G，HOU N Y，et al. ATP⁃dependent
⁃ related renal fibrosis by maintaining mitochondrial ho⁃ LON protease contributes to helicobacter pylori⁃induced
meostasis［J］. J Cell Mol Med，2024，28（17）：e70090 gastric carcinogenesis［J］. Neoplasia（NY），2016，18（4）：
［34］FU T，SUN W，XUE J et al. Proteolytic rewiring of mito⁃ 242-252
chondria by LONP1 directs cell identity switching of adi⁃ ［47］ZHONG Y，WU L，PENG Z，et al. LONP1 Promotes hepa⁃
pocytes［J］. Nat Cell Biol，2023，25（6）：848-864 tocarcinogenesis by degrading ACO2 to alleviate ferropto⁃
［35］TANG Y，LIU Y X，SHENG Y，et al. The first case report sis［J］. Front Biosci（Landmark Ed），2025，30（8）：41226
of CODAS syndrome in Chinese population caused by two ［48］YAO M，ZHANG X，WU T，et al. LON protease 1⁃mediat⁃
LONP1 pathogenic mutations［J］. Front Genet，2023，13： ed metabolic reprogramming promotes the progression of

1031856 prostate cancer［J］. Cell Death Dis，2025，16（1）：116
［36］NIMMO G A M，VENKATESH S，PANDEY A K，et al. Bi⁃ ［49］BERNSTEIN S H，VENKATESH S，LI M，et al. The mito⁃
allelic mutations of LONP1 encoding the mitochondrial chondrial ATP⁃dependent LON protease：a novel target in
LonP1 protease cause pyruvate dehydrogenase deficiency lymphoma death mediated by the synthetic triterpenoid
and profound neurodegeneration with progressive cerebel⁃ CDDO and its derivatives［J］. Blood，2012，119（14）：
lar atrophy［J］. Hum Mol Genet，2019，28（2）：290-306 3321-3329
［37］LI S，HE N，LIAO J，et al. Association of LONP1 gene ［50］MANEIX L，SWEENEY M A，LEE S，et al. The mitochon⁃
with epilepsy and the sub ⁃ regional effect［J］. Sci Rep， drial protease LONP1 promotes proteasome inhibitor re⁃
2024，14（1）：25575 sistance in multiple myeloma［J］. Cancers，2021，13（4）：
［38］PETER B，WADDINGTON C L，OLÁHOVÁ M，et al. De⁃ 843
fective mitochondrial protease LonP1 can cause classical ［51］MUTHU S，TRAN Z，THILAGAVATHI J，et al. Aging trig⁃
mitochondrial disease［J］. Hum Mol Genet，2018，27 gers mitochondrial，endoplasmic reticulum，and metabolic
（10）：1743-1753 stress responses in the heart［J］. J Cardiovasc Aging，
［39］HANNAH⁃SHMOUNI F，MACNEIL L，BRADY L，et al. 2025，5（1）：4
Expanding the clinical spectrum of LONP1⁃related mito⁃ ［52］ZHAO K，HUANG X Y，ZHAO W K，et al. LONP1⁃medi⁃
chondrial cytopathy［J］. Front Neurol，2019，10：981 ated mitochondrial quality control safeguards metabolic
［40］QIAO L，XU L，YU L，et al. Rare and de novo variants in shifts in heart development［J］. Development，2022，149
827 congenital diaphragmatic hernia probands implicate （6）：dev200458
LONP1 as candidate risk gene［J］. Am J Hum Genet， ［53］SEPURI N B V，ANGIREDDY R，SRINIVASAN S，et al.
2021，108（10）：1964-1980 Mitochondrial LON protease⁃dependent degradation of cy⁃
［41］SHETTY R，NOLAND R，NANDI G，et al. Powering down tochrome C oxidase subunits under hypoxia and myocardi⁃
the mitochondrial LONP1 protease：a novel strategy for an⁃ al ischemia［J］. Biochim Biophys Acta Bioenerg，2017，